Nitin Nitin to Antibodies, Monoclonal, Murine-Derived
This is a "connection" page, showing publications Nitin Nitin has written about Antibodies, Monoclonal, Murine-Derived.
Connection Strength
0.469
-
Targeted therapy with MXD3 siRNA, anti-CD22 antibody and nanoparticles for precursor B-cell acute lymphoblastic leukaemia. Br J Haematol. 2014 Nov; 167(4):487-99.
Score: 0.469